PTP — Pentixapharm Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00- €53.53m
- €48.91m
- €0.09m
Annual cashflow statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 41 W | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -12.8 | -16.5 |
| Depreciation | ||
| Deferred Taxes | ||
| Non-Cash Items | -0.036 | 0.145 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -6.78 | -2.32 |
| Change in Accounts Receivable | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Cash from Operating Activities | -4.33 | -18 |
| Capital Expenditures | -0.001 | -0.625 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 8.24 | — |
| Acquisition of Business | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 8.24 | -0.625 |
| Financing Cash Flow Items | 19.3 | 0 |
| Other Financing Cash Flow | ||
| Cash from Financing Activities | 19.3 | 0 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 23.2 | -18.6 |